Buprenorphine-Naloxone in the Treatment of Codeine Dependence: a Scoping Review of Clinical Case Presentations

  • Marie Claire Van Hout
  • Evelyn Hearne
  • Michael Bergin
Article

Abstract

Misuse of prescribed and over the counter (OTC) codeine containing medicines is an increasing public health concern in recent times. Studies have called for low threshold treatment services for individuals experiencing codeine dependence using buprenorphine naloxone therapy. We present a scoping review of clinical case presentation literature on the use of buprenorphine-naloxone in the treatment of codeine dependence. Seven records (four single case studies and three case series) on codeine dependence treated with buprenorphine-naloxone were included. Five themes emerged following a review of the cases for the treatment of codeine dependence with buprenorphine-naloxone. They are: (1) Patient Profiles; (2) History of Codeine Misuse; (3) Medical Problems; (4) Use of Other Substances; and (5) Buprenorphine-naloxone in the treatment of Codeine Dependence. The review highlights the complexities of patients with regards to pain, psychiatric illness, poly substance use and iatrogenic dependence, with findings encouraging in terms of patient stabilisation and recovery.

Keywords

Codeine Dependence Buprenorphine Buprenorphine-naloxone 

References

  1. Anderson, S., Allen, P., Peckham, S., & Goodwin, N. (2008). Asking the right questions: scoping studies in the commissioning of research on the organization and delivery of health services. Health Research Policy and Systems, 6, 1–12.CrossRefGoogle Scholar
  2. Arskey, H., & O’Malley, L. (2005). Scoping studies: towards a methodological framework. International Journal of Social Research Methodology, 8(1), 9–32.Google Scholar
  3. Babalonis, S., Lofwall, M. R., Nuzzo, P. A., Siegel, A. J., & Walsh, S. L. (2013). Abuse liability and reinforcing efficacy of oral tramadol in humans. Drug and Alcohol Dependence, 129(1–2), 116–124.CrossRefPubMedGoogle Scholar
  4. Bergin, M., Norman, I., Foley, M., Harris, R., Rapca, A., Rich, E., & Van Hout, M. C. (2015). Practice implications and recommendations for managing codeine misuse and dependence. Acta Pharmaceutica, 65(4), 351–364.CrossRefPubMedGoogle Scholar
  5. Brien, S. E., Lorenzetti, D. L., Lewis, S., Kennedy, J., & Ghali, W. A. (2010). Overview of a formal scoping review on health system report cards. Implementation Science, 15(5), 2.CrossRefGoogle Scholar
  6. Casati, A., Sedefov, R., & Pfeiffer-Gerschel, T. (2012). Misuse of medicines in the European Union: a systematic review of the literature. European Addiction Research, 18(5), 228–245. doi:10.1159/000337028.CrossRefPubMedGoogle Scholar
  7. Conroy, S., & Hill, D. (2014). Failure to identify or effectively manage prescription opioid dependence acted as a gateway to heroin use—buprenorphine/naloxone treatment and recovery in a surgical patient. BMJ Case Reports, 17. doi:10.1136/bcr-2014-207458.
  8. Cooper, R. J. (2011). ‘Respectable addiction’—A qualitative study of over the counter medicine abuse in the UK. London: Pharmacy Practice Research Trust.Google Scholar
  9. Cooper, R. J. (2013). ‘I can’t be an addict. I am.’ Over-the-counter medicine abuse: a qualitative study. BMJ Open, 3(6), e002913.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Daudt, H. M. L., van Mossel, C., & Scott, S. J. (2013). Enhancing the scoping study methodology: a large, inter-professional team’s experience with Arksey and O’Malley’s framework. BMC Medical Research Methodology, 13, 48.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Department of Health (England) and the developed administrations. (2007). Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive.Google Scholar
  12. Derry, S., Karlin, S. M., & Moore, R. A. (2013). Single dose oral ibuprofen plus codeine for acute postoperative pain in adults. The Cochrane Database Systematic Review, 3. doi:10.1002/14651858.CD010107.pub2.
  13. Dobbin, M., & Tobin, C. (2008). Over-the-counter (OTC) ibuprofen/codeine analgesics: Misuse and harm. Melbourne: Drugs Policy and Services Branch, Department of Human Services, Victoria.Google Scholar
  14. Dutch, M. J. (2008). Nurofen Plus misuse: an emerging cause of perforated gastric ulcer. Medical Journal of Australia, 188(1), 56–57.PubMedGoogle Scholar
  15. Ernest, D., Chia, M., & Corallo, C. E. (2010). Profound hypokalaemia due to Nurofen Plus and Red Bull. Critical Care and Resuscitation, 12(2), 109–110.PubMedGoogle Scholar
  16. Evans, C., Chalmers-Watson, T. A., & Gearry, R. B. (2010). Combination NSAID-codeine preparations and gastrointestinal toxicity. New Zealand Medical Journal, 123(1324), 92–93.PubMedGoogle Scholar
  17. Fareed, A., Vayalapalli, S., Casarella, J., & Drexler, K. (2012). Effect of burprenorphine dose on treatment outcome. Journal of Addictive Diseases, 31(1), 8–18. doi:10.1080/10550887.2011.642758.CrossRefPubMedGoogle Scholar
  18. Fiellin, D. A., Schottenfeld, R. S., Cutter, C. J., Moore, B. A., Barry, D. T., & O’Connor, P. G. (2014). Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial. JAMA Internal Medicine, 174(12), 1947–1954. doi:10.1001/jamainternmed.2014.5302.CrossRefPubMedGoogle Scholar
  19. Fine, P. G., Portenoy, R. K., & Ad Hoc Expert Panel on Evidence Review and Guidelines for Opioid Rotation. (2009). Establishing ‘best practices’ for opioid rotation: conclusions of an expert panel. Journal of Pain and Symptom Management, 38(3), 418–425.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Frei, M. Y., Nielsen, S., Dobbin, M. D., & Tobin, C. L. (2010). Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases. The Medical Journal of Australia, 193(5), 294–296.PubMedGoogle Scholar
  21. Gowing, L., Ali, R., Dunlop, A., Farrell, M., & Lintzeris, N. (2014). National guidelines for medication-assisted treatment of opioid dependence. Canberra: National Drug Strategy.Google Scholar
  22. Handley, S. A., & Flanagan, R. J. (2014). Drugs and other chemicals involved in fatal poisoning in England and Wales during 2000–2011. Clinical Toxicology (Philadelphia, Pa.), 52(1), 1–12. doi:10.3109/15563650.2013.872791.CrossRefGoogle Scholar
  23. Hard, B. (2014). Management of opioid painkiller dependence in primary care: ongoing recovery with buprenorphine/naloxone. BMJ Case Reports. doi:10.1136/bcr-2014-207308.PubMedPubMedCentralGoogle Scholar
  24. Hidalgo Landa, A., Szabo, I., Le Brun, L., Owen, I., & Fletcher, G. (2011). Evidence based scoping reviews. The Electronic Journal Information Systems Evaluation, 14, 46–52.Google Scholar
  25. Ingelman-Sundberg, M., Sim, S. C., Gomez, A., & Rodriguez-Antona, C. (2007). Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacology and Therapeutics, 116(3), 496–526.CrossRefPubMedGoogle Scholar
  26. Kean, J. (2015). Illicit and over-the-counter codeine dependence after acute back pain-successful treatment and ongoing recovery after buprenorphine/naloxone taper. Heroin Addiction and Related Clinical Problems, Published Ahead of Print, October 18, 2015.Google Scholar
  27. Kelly, L. E., & Madadi, P. (2012). Is there a role for therapeutic drug monitoring with codeine? Therapeutic Drug Monitoring, 34(3), 249–256.CrossRefPubMedGoogle Scholar
  28. Lambert, A. P., & Close, C. (2005). Life-threatening hypokalaemia from abuse of nurofen plus. Journal of the Royal Society of Medicine, 98(1), 21.CrossRefPubMedPubMedCentralGoogle Scholar
  29. Levac, D., Colquhoun, H., & O’Brien, K. K. (2010). Scoping studies: advancing the methodology. Implementation Science, 5, 69.CrossRefPubMedPubMedCentralGoogle Scholar
  30. Manchia, M., Alda, M., & Clakin, C. (2013). Repeated erythromycin/codeine-induced psychotic mania. Clinical Neuropharmacology, 36(5), 177–178.CrossRefPubMedGoogle Scholar
  31. Marr, E., & Hill, D. (2015). Optimising service provision for prescribed opioid analgesic dependence. Heroin Addiction and Related Clinical Problems, 17(5).Google Scholar
  32. McAvoy, B. R., Dobbin, M., & Tobin, C. (2011). Over-the-counter codeine analgesic misuse and harm: characteristics of cases in Australia and New Zealand. New Zealand Medical Journal, 124(1346), 29–33.PubMedGoogle Scholar
  33. McDonough, M. A. (2011). Misuse of codeine-containing combination analgesics. Medical Journal of Australia, 194(9), 486.PubMedGoogle Scholar
  34. Ministry of Health. (2014). New Zealand practice guidelines for opioid substitution treatment. Wellington: Ministry of Health.Google Scholar
  35. Myers, B., Siegfried, N., & Parry, C. D. (2003). Over-the-counter and prescription medicine misuse in Cape Town-findings from specialist treatment centres. South African Medical Journal, 93(5), 367.PubMedGoogle Scholar
  36. National Institute for Health and Clinical Excellence. (2007). Methadone and buprenorphine for the management of opioid dependence. NICE technology appraisal guidance [TA114]. https://www.nice.org.uk/guidance/ta114. Accessed 15 Feb 2016.
  37. Ng, J., Morgan, D., Loh, N., Gan, S., Coleman, P., Ong, G., & Prentice, D. (2011). Life-threatening hypokalaemia associated with ibuprofen-induced renal tubular acidosis. Medical Journal of Australia, 194(6), 313–316.PubMedGoogle Scholar
  38. Nielsen, S., Cameron, J., & Lee, N. (2011). Characteristics of a non-treatment-seeking sample of over-the-counter codeine users: implications for intervention and prevention. Journal of Opioid Management, 7(5), 363–370.Google Scholar
  39. Nielsen, S., Cameron, J., & Pahoki, S. (2010). Over the counter codeine dependence. Victoria: Turning Point Drug and Alcohol Centre.Google Scholar
  40. Nielsen, S., Hillhouse, M., Mooney, L., Fahey, J., & Ling, W. (2012). Comparing buprenorphine induction experience with heroin and prescription opioid users. Journal of Substance Abuse Treatment, 43(3), 285–290. doi:10.1016/j.jsat.2011.12.009.CrossRefPubMedPubMedCentralGoogle Scholar
  41. Nielsen, S., Cameron, J., & Pahoki, S. (2013). Opportunities and challenges: over the counter codeine supply from the codeine consumer perspective. International Journal of Pharmacy Practice, 21(3), 161–168.CrossRefPubMedGoogle Scholar
  42. Nielsen, S., Roxburgh, A., Bruno, R., Lintzeris, N., Jefferson, A., & Degenhardt, L. (2015a). Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011. Drug and Alcohol Dependence, 149, 212–219. doi:10.1016/j.drugalcdep.2015.02.004.CrossRefPubMedGoogle Scholar
  43. Nielsen, S., Bruno, R., Murnion, B., Dunlop, A., Degenhardt, L., Demirkol, A., Muhleisen, P., & Lintzeris, N. (2015b). Treating codeine dependence with buprenorphine: dose requirements and induction outcomes from a retrospective case series in New South Wales, Australia. Drug and Alcohol Review. doi:10.1111/dar.12315. Early Online.Google Scholar
  44. Nielsen, S., Murnion, B., Dunlop, A., Degenhardt, L., Demirkol, A., Muhleisen, P., Litzeris, N., & Litzeris, N. (2015c). Comparing treatment-seeking codeine users and strong opioid users: findings from a novel case series. Drug and Alcohol Review, 34(3), 30a4–30a11. doi:10.1111/dar.12315.CrossRefGoogle Scholar
  45. Nielsen, S., Murnion, B., Dunlop, A., Degenhardt, L., Demirkol, A., Muhleisen, P., & Lintzeris, N. (2015d). Comparing treatment-seeking codeine users and strong opioid users: findings from a novel case series. Drug and Alcohol Review, 34(3), 304–311. doi:10.1111/dar.12224.CrossRefPubMedGoogle Scholar
  46. Nielsen, S., Bruno, R., Murnion, B., Dunlop, A., Degenhardt, L., Demirkol, A., Muhleisen, P., & Lintzeris, N. (2015e). Treating codeine dependence with buprenorphine: dose requirements and induction outcomes from a retrospective case series in New South Wales, Australia. Drug and Alcohol Review. doi:10.1111/dar.12315.Google Scholar
  47. Pham, M. T., Rajić, A., Greig, J. D., Sargeant, J. M., Papadopoulos, A., & McEwen, S. A. (2014). A scoping review of scoping reviews: advancing the approach and enhancing the consistency. Research Synthesis Methods, 5, 371–385.CrossRefPubMedPubMedCentralGoogle Scholar
  48. Pilgrim, J. L., Dobbin, M., & Drummer, O. H. (2013). Fatal misuse of codeine-ibuprofen analgesics in Victoria, Australia. Medical Journal of Australia, 199(5), 329–331.CrossRefPubMedGoogle Scholar
  49. Reed, K., Bond, A., Witton, J., Cornish, R., Hickman, M., & Strang, J. (2011). The changing use of prescribed benzodiazepines and z-drugs and of over-the-counter codeine-containing products in England: A structured review of published English and international evidence and available data to inform consideration of the extent of dependence and harm. London: National Addiction Centre.Google Scholar
  50. Romach, M. K., Sproule, B. A., Sellers, E. M., Somer, G., & Busto, U. E. (1999). Long-term codeine use is associated with depressive symptoms. Journal of Clinical Psychopharmacology, 19(4), 373–376.CrossRefPubMedGoogle Scholar
  51. Rumrill, P. D., Fitzgerald, S. M., & Merchant, W. (2010). Speaking of research: using scoping literature reviews as a means of understanding and interpreting existing literature. Work, 35(3), 399–404.PubMedGoogle Scholar
  52. Sigmon, S. C., Dunn, K. E., Badger, G. J., Heil, S. H., & Higgins, S. T. (2009). Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study. Addictive Behaviors, 34, 304–311.CrossRefPubMedGoogle Scholar
  53. Sproule, B. A., Busto, U. E., Somer, G., Romach, M. K., & Sellers, E. M. (1999). Characteristics of dependent and nondependent regular users of codeine. Journal of Clinical Psychopharmacology, 19(4), 367–372.CrossRefPubMedGoogle Scholar
  54. Stannard, C. (2013). Opioids in the UK: what’s the problem? BMJ, 15(347), f5108. doi:10.1136/bmj.f5108.CrossRefGoogle Scholar
  55. The Royal College of General Practitioners. (2014a). Prescription and over-the-counter medicines misuse and dependence. Fact Sheet 1. The Problem. The Royal College of General Practitioners Substance Misuse and Associated Health unit Public Health England.Google Scholar
  56. The Royal College of General Practitioners. (2014b). Prescription and over-the-counter medicines misuse and dependence. Fact Sheet 2. Prevention. The Royal College of General Practitioners Substance Misuse and Associated Health unit Public Health England.Google Scholar
  57. The Royal College of General Practitioners. (2014c). Prescription and over-the-counter medicines misuse and dependence. Fact Sheet 3. Identification. The Royal College of General Practitioners Substance Misuse and Associated Health unit Public Health England. The Royal College of General Practitioners. (2014d). Prescription and over-the-counter medicines misuse and dependence. Fact Sheet 4. Treatment. The Royal College of General Practitioners Substance Misuse and Associated Health unit Public Health England.Google Scholar
  58. Tobin, C., Dobbin, M., & McAvoy, B. (2013). Regulatory responses to over-the-counter codeine analgesic misuse in Australia, New Zealand and the United Kingdom. Australian and New Zealand Journal of Public Health, 37, 483–488.CrossRefPubMedGoogle Scholar
  59. Tremlett, M., Anderson, B. J., & Wolf, A. (2010). Pro-con debate: is codeine a drug that still has a useful role in pediatric practice? Paediatric Anaesthesia, 20(2), 183–194.CrossRefPubMedGoogle Scholar
  60. Van Hout, M. C. (2015). Nod and wave: an internet study of the codeine intoxication phenomenon. The International Journal on Drug Policy, 26(1), 67–77.CrossRefPubMedGoogle Scholar
  61. Van Hout, M. C., & Norman, I. (2015). Misuse of non-prescription codeine containing products: recommendations for detection and reduction of risk in community pharmacies. The International Journal on Drug Policy, 27, 17–22.CrossRefPubMedGoogle Scholar
  62. Van Hout, M. C., Bergin, M., Foley, M., Rich, E., Rapca, A. I., Harris, R., & Norman, I. (2014). A scoping review of codeine use, misuse and dependence, final report. Brussels: CODEMISUSED Project European Commission 7th Framework Programme.Google Scholar
  63. Van Hout, M. C., Horan, A., Santlal, K., Rich, E., & Bergin, M. (2015a). ‘Codeine is my Companion’: Misuse and dependence on codeine containing medicines in Ireland. Irish Journal of Psychological Medicine. Early Online.Google Scholar
  64. Van Hout, M. C., Rich, E., Dada, S., & Bergin, M. (2015b). Codeine is my helper: a qualitative study of pharmacy access and codeine misuse in South Africa. Qualitative Health Research. doi:10.1177/1049732315613764. Early Online.PubMedGoogle Scholar
  65. Van Hout, M. C., Delargy, I., Ryan, G., Flanagan, S., & Gallagher, H. (2015c). Dependence on over the counter (otc) codeine containing analgesics: treatment and recovery with buprenorphine naloxone. International Journal of Mental Health and Addiction, First online: 14 December 2015, 1–11.Google Scholar
  66. Weiss, R. D., Potter, J. S., Fiellin, D., Byrne, M., Connery, H. S., Diskinson, W., & Ling, W. (2011). A two-phase randomized controlled TRIAL of adjunctive counselling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence. Archives of General Psychiatry, 68(12), 1238–1246.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Marie Claire Van Hout
    • 1
  • Evelyn Hearne
    • 1
  • Michael Bergin
    • 1
  1. 1.School of Health SciencesWaterford Institute of TechnologyWaterfordIreland

Personalised recommendations